Filing Flows › Bio Green Med Solution (BGMS) › Who owns the stock
Who owns Bio Green Med Solution (BGMS) stock
9 funds reported Bio Green Med Solution (BGMS) shares in their latest 13F filings, worth $93K in all. The largest holder is Citadel Advisors LLC ($68K). Last quarter 2 funds added to their stakes and 6 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Citadel Advisors LLC | 75,240 | $68K | increase | 2026-06-30 |
| Jane Street Group, LLC | 16,291 | $15K | new | 2026-06-30 |
| Tower Research Capital LLC | 5,722 | $5K | increase | 2026-06-30 |
| UBS Group AG | 4,332 | $4K | increase | 2026-06-30 |
| SBI Securities | 701 | $1K | increase | 2026-06-30 |
| Root Financial Partners, LLC | 7 | $6 | new | 2026-09-30 |
| Barclays | 4 | $4 | new | 2026-09-30 |
| Archer Investment | 2 | $2 | increase | 2026-06-30 |
| Osaic Holdings | 1 | $0 | unchanged | 2026-06-30 |
Bio Green Med Solution's latest quarter
Bio Green Med Solution, Q2 2026: revenue $357K, operating margin -117.1%, net loss $405K, operating cash flow −$352K. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most BGMS stock?
By the latest 13F filings: Citadel Advisors LLC ($68K); Jane Street Group, LLC ($15K); Tower Research Capital LLC ($5K); UBS Group AG ($4K); SBI Securities ($1K).
What is the short interest in BGMS?
30,190 shares were sold short at the 2026-10-15 settlement, 439.97% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.